Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
To decide whether progesterone supplementation in threatened abortion is a sound practice.
This study was conducted at Obstetrics and Gynecology Department, Tanta University in the period from January 2018 to December 2018. Patients: Eligible patients (n=190) were randomly allocated into 2 groups; study group who will receive progesterone supplementation (Prog.group) and control group who will receive no treatment (place.group).
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Progesterone | Experimental | received rectal progesterone suppositories 400 mg once daily |
|
| Control group | Placebo Comparator | received placebo suppositories rectally once daily. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Progesterone | Drug | received rectal progesterone suppositories 400 mg once daily |
| |
| Measure | Description | Time Frame |
|---|---|---|
| relief of pain | questionnaire fulfilled by patient with yes or no questions | 3 weeks |
| completion of pregnancy beyond 20 weeks | passing the age 20 weeks | 12 weeks |
| Stoppage of bleeding | Cessation of bleeding | 3 weeks |
| Measure | Description | Time Frame |
|---|---|---|
| abortion less than 20 weeks. | Abortion | 12 weeks |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Ayman Shehata Dawood | Tanta | Egypt |
Not provided
2 months
Not provided
Not provided
Not provided
| ID | Term |
|---|---|
| D000033 | Abortion, Threatened |
| C564871 | Progesterone Resistance |
| ID | Term |
|---|---|
| D011248 | Pregnancy Complications |
| D005261 | Female Urogenital Diseases and Pregnancy Complications |
| D000091642 | Urogenital Diseases |
Not provided
Not provided
| ID | Term |
|---|---|
| D011374 | Progesterone |
| ID | Term |
|---|---|
| D011282 | Pregnenediones |
| D011283 | Pregnenes |
| D011278 | Pregnanes |
| D013256 | Steroids |
| D000072473 |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Placebos |
| Drug |
received placebo suppositories rectally once daily. |
|
| Fused-Ring Compounds |
| D011083 | Polycyclic Compounds |
| D003339 | Corpus Luteum Hormones |
| D042341 | Gonadal Hormones |
| D006728 | Hormones |
| D006730 | Hormones, Hormone Substitutes, and Hormone Antagonists |
| D045167 | Progesterone Congeners |
| D012739 | Gonadal Steroid Hormones |